David Esopi
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Epigenetics and DNA Methylation 6
- RNA modifications and cancer 5
- Cancer-related gene regulation 4
- DNA Repair Mechanisms 2
-
- Prostate Cancer Treatment and Research 11
- Co-authors
- Srinivasan Yegnasubramanian (22 shared papers)Angelo M. De Marzo (16 shared papers)Michael C. Haffner (14 shared papers)William G. Nelson (13 shared papers)William B. Isaacs (8 shared papers)Alan K. Meeker (6 shared papers)G. Steven Bova (3 shared papers)George J. Netto (4 shared papers)
- Journals
- The Prostate (3 papers)PLoS ONE (3 papers)Cancer Research (3 papers)Oncotarget (3 papers)The Journal of Pathology (3 papers)
- Partner nations
- United StatesChinaIsrael
In The Last Decade
David Esopi
25 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 98
- Cancer Research 626
- Pulmonary and Respiratory Medicine 895
- Molecular Biology 1.4k
- Oncology 363
- Rheumatology 105
Countries citing papers authored by David Esopi
This map shows the geographic impact of David Esopi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Esopi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Esopi more than expected).
Fields of papers citing papers by David Esopi
This network shows the impact of papers produced by David Esopi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Esopi. The network helps show where David Esopi may publish in the future.
Co-authors
The 25 scholars most cited alongside David Esopi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 456 | |
| 2 | 2011 | 363 | |
| 3 | 2013 | 362 | |
| 4 | 2010 | 315 | |
| 5 | 2011 | 262 | |
| 6 | 2013 | 204 | |
| 7 | 2012 | 92 | |
| 8 | 2013 | 86 | |
| 9 | 2015 | 76 | |
| 10 | 2011 | 53 | |
| 11 | 2017 | 46 | |
| 12 | 2018 | 43 | |
| 13 | 2013 | 41 | |
| 14 | 2017 | 39 | |
| 15 | 2015 | 35 | |
| 16 | 2011 | 35 | |
| 17 | 2014 | 32 | |
| 18 | 2018 | 29 | |
| 19 | 2015 | 23 | |
| 20 | 2019 | 16 |
About David Esopi
David Esopi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Rheumatology, having authored 26 papers that have together received 2.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (11 papers), Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (5 papers), Cancer-related gene regulation (4 papers), Cancer Genomics and Diagnostics (3 papers), Telomeres, Telomerase, and Senescence (3 papers), DNA Repair Mechanisms (2 papers) and Urologic and reproductive health conditions (2 papers). The work is most often cited by research in Cancer Research (626 citations), Pulmonary and Respiratory Medicine (895 citations), Molecular Biology (1.4k citations), Oncology (363 citations) and Rheumatology (105 citations). David Esopi has collaborated with scholars based in United States, China and Israel. Frequent co-authors include Srinivasan Yegnasubramanian, Angelo M. De Marzo, Michael C. Haffner, William G. Nelson, William B. Isaacs, Alan K. Meeker, G. Steven Bova, George J. Netto, Jianfeng Xu and Wennuan Liu. Their work appears in journals such as The Prostate, PLoS ONE, Cancer Research, Oncotarget and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.